ALG-005398

N/A

Report date: 2025/06/10 15:04:54
NME

Base Information

Drug NameALG-005398
Drug Alias NameALG-005398
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulatorsHBsAg inhibitors
TargetsCapsid proteinHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAligos Belgium BV
China Registration ClassN/A

Develop Information

Active CompaniesAligos Belgium BV
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A